{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Northwestern Medicine | Northwestern University | Faculty Profiles
Feinberg School of Medicine - NorthwesternLogo
  • Sign In
  • Live Courses
  • RSS Calendar
  • Online Courses
  • NM Learning
  • Licensing Requirements
  • Planners
  • About Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Northwestern Medicine providers only - click the top button and log in using the same username and password you currently use for other NM Applications such as EPIC If you do not recall your user name and password, contact NM Help desk at 312-926-4357 or [email protected].  When speaking to the NM Help Desk, be sure to ask for assistance with your NM ID and the associated password.  Instructions on logging in remotely can be found here.  

Do not ask NM Help Desk for assistance with the CME website.  Contact the Office of CME directly at (312) 503-8533. 

All others - please login with the email address and password used to create your account.  If you have forgotten your login credentials to create an account, click "Sign In with your email and password" and you will be directed to create an account or retrieve a password.

Learners with a Lurie Children's email address should choose "Sign In with your email and password".

Sign in with your Northwestern Medicine ID
Sign in with your email and password
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • APRN
  • BSN
  • BSRT
  • CCT
  • CNM
  • CRA
  • CRNA
  • CRNP
  • CTR
  • CVT
  • DDS
  • DMD
  • DO
  • DPM
  • DPT
  • EMT
  • EMT-P
  • JD
  • LCSW
  • LNM
  • LPN
  • MA
  • MBA
  • MBBS
  • MBChB
  • MD
  • MD, JD
  • MD, MBA
  • MD, MPH
  • MD, MS
  • MD, PhD
  • MPH
  • MS
  • MSN
  • MSPH
  • MSW
  • None
  • NP
  • Other
  • OTR
  • PA
  • PharmD
  • PhD
  • PT
  • RCES
  • RCS
  • RD
  • RDCS
  • RDMS
  • RN
  • RN, BSN
  • RT
  • RTT
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

22nd Annual Lynn Sage Breast Cancer Symposium

  • Overview
  • Faculty
  • Brochure
  • Tests
Add to Calendar 22nd Annual Lynn Sage Breast Cancer Symposium 9/10/2020 8:15:00 AM 9/12/2020 4:25:00 PM America/Chicago For More Details: https://northwestern.cloud-cme.com/course/courseoverview?EID=79401 Description: This educational initiative was developed to bring together leading national and international medical, surgical, and radiation oncologists to present, debate, and evaluate cutting-edge technology and approaches in the management of breast cancer. Online false MM/DD/YYYY


Date & Location
Thursday, September 10, 2020, 8:15 AM - Saturday, September 12, 2020, 4:25 PM, Online

Target Audience
Specialties - Family Practice, General Surgery, Nurse Practitioner, Nursing, Oncology, Physician Assistant, Radiology

Overview
This educational initiative was developed to bring together leading national and international medical, surgical, and radiation oncologists to present, debate, and evaluate cutting-edge technology and approaches in the management of breast cancer.

Objectives
  1. Develop new strategies for the optimal evaluation and management of women at increased risk for breast cancer
  2. Analyze application of neoadjuvant endocrine therapy in operable cancer
  3. Describe role of new technology in radiology and radiotherapy
  4. Identify new approaches to systemic therapy and how they may influence surgical management

Registration

Physician $375

LMIC* Physician $100

Nurse/Nurse Practitioner/Fellow/Other Allied Health $75

LMIC* Nurse/Nurse Practitioner/Fellow/Other Allied Health $25

Industry $595

*Registrants who reside in LMIC countries as defined by the World Bank Group.  

Refund/Cancellation Policy:

Registration fees, less a $50 administrative handling fee, are refundable if written request is received on or before August 15, 2020. Please include your registration ID when requesting a refund. No refunds will be granted after August 15, 2020. However, you may transfer your registration to  a colleague.


Accreditation

The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 16.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Additional Information

Questions? Please call the Lurie Cancer Center at 312.503.7809, or email [email protected]. 


Credits
AMA PRA Category 1 Credits™ (16.25 hours), ABIM MOC Part 2 (16.25 hours), Non-Physician Attendance (16.25 hours)

Carey Anders, MD
Banu Arun, MD
Luis Z Blanco Jr., MD
Physician CE
Northwestern University Feinberg School of Medicine
Chicago, IL
Richard Bleicher, MD
Steven Chmura, MD, PhD
Massimo Cristofanilli, MD
Northwestern University-Robert H Lurie Comprehensive Cancer Center
Chicago, IL
Eric D Donnelly, MD
Northwestern Memorial Hospital, Robert. H. Lurie Comprehensive Cancer Center
Chicago, IL
Anthony Elias, MD
Mary Gemignani, MD, MPH
William J Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, IL
Nora M Hansen, MD
Professor of Surgery
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, IL
Dawn Hershman, MD, MS
Reshma Jagsi, MD, PhD
Maxine Jochelson, MD
Memorial Sloan Kettering Cancer Center
New York, NY
Virginia G Kaklamani, MD
UT Health San Antonio MD Anderson Cancer Center
San Antonio, TX
Steven Katz, MD, MPH
University of Michigan
Ann Arbor, MI
Seema Khan, MD
Physician CE
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, IL
Tari King, MD
Harvard Medical School Dana-Farber Cancer Institute
Boston, MA
Sheetal M Kircher, MD
Physician CE
Northwestern Medical Group
Chicago, IL
Constance Lehman, MD, PhD
Sarah McLaughlin, MD
Otto Metzger, MD
Harvard Medical School Dana-Farber Cancer Institute
Boston, MA
Tracy Ann SKC Moo, MD
Memorial Sloan Kettering Cancer Center
New York, NY
Monica Morrow, MD
MD
Memorial Sloan Kettering Cancer Center
New York, NY
Jonas Nelson, MD, MPH
Lajos Pusztai, MD, PhD
David Rimm, MD, PhD
Stuart Schnitt, MD
Harvard Medical School Dana-Farber Cancer Institute
Boston, MA
Popi P Siziopikou, MD,PhD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, IL
Jonathan Strauss, MD, MBA
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, IL
Julia White, MD
Ohio State University James Comprehensive Cancer Center
Columbus, OH
Kari Wisinski, MD

Thursday, September 10, 2020
Optional Non-CME Sponsored by Immunomedics: Learn More About an FDA-Approved Treatment for Metastatic Triple-Negative Breast Cancer
8:15AM - 9:00AM
Symposium Welcome
9:00AM - 9:05AM
William J Gradishar, MD
Managing the Side Effects of Endocrine Therapy
9:05AM - 9:35AM
Dawn Hershman, MD, MS
New Approaches to Pain Management in Breast Surgery
9:35AM - 10:05AM
Tracy Ann SKC Moo, MD
Current Considerations for Lymphedema Diagnosis and Treatment
10:05AM - 10:35AM
Sarah McLaughlin, MD
Break
10:35AM - 10:50AM
Delivering Survivorship Care
10:50AM - 11:20AM
Sheetal M Kircher, MD
Q&A
11:20AM - 11:35AM
Lunch Break & Exhibits
11:35AM - 12:05PM
Optional Non-CME: Sponsored by Lilly A Treatment Option for Patients With HR+, HER2- Advanced or Metastatic Breast Cancer
11:35AM - 12:05PM
Break
12:05PM - 12:10PM
Evaluation of Pathologic Response After Neoadjuvant Chemotherapy: A Continuing Challenge
12:10PM - 12:40PM
Popi P Siziopikou, MD,PhD
PDL-1 Assessment: What’s Important, What’s Not?
12:40PM - 1:10PM
David Rimm, MD, PhD
WHO Classification of Breast Tumors: The 2019 Update
1:10PM - 1:40PM
Luis Z Blanco Jr., MD
Genomic Tools That Predict Response in Breast Cancer
1:40PM - 2:10PM
Virginia G Kaklamani, MD
Q&A
2:10PM - 2:25PM
Adjourn
2:25PM - 2:30PM
Friday, September 11, 2020
Optional Non-CME: Sponsored by Pfizer Innovative Oral Treatment Options for Patients: HR+/HER2- mBC or gBRCA-Mutated Triple-Negative and HR+/HER2- mBC
7:45AM - 9:00AM
Update on Contrast Mammography
9:00AM - 9:30AM
Maxine Jochelson, MD
Machine Learning as a Tool to Improve Breast Imaging
9:30AM - 10:00AM
Constance Lehman, MD, PhD
Assessing Genetic Risk 2020
10:00AM - 10:30AM
Banu Arun, MD
Break
10:30AM - 10:45AM
Controversies in Surgical Management of BRCA Carriers
10:45AM - 11:15AM
Mary Gemignani, MD, MPH
Genetic Testing in Practice: Perceptios of Patients and Physicians
11:15AM - 11:45AM
Steven Katz, MD, MPH
Q&A
11:45AM - 12:00PM
Lunch Break & Exhibits
12:00PM - 12:40PM
Optional Non-CME: Sponsored by Seattle Genetics TUKYSATM (tucatinib): A NEW TREATMENT OPTION for Patients with HER2+ Metastatic Breast Cancer (MBC)
12:05PM - 12:40PM
Male Breast Cancer: Is it Really Worse?
12:40PM - 1:10PM
Anthony Elias, MD
Detection and Treatment of Minimal Residual Disease: The Way Forward?
1:10PM - 1:40PM
Lajos Pusztai, MD, PhD
Patterns of Tumor Response Following NAC: Implications for Local Therapy
1:40PM - 2:10PM
Stuart Schnitt, MD
Break
2:10PM - 2:25PM
Proton Radiotherapy for Breast Cancer: Advance or Fad?
2:25PM - 2:55PM
Jonathan Strauss, MD, MBA
Delay in Breast Cancer Treatment: Is it Harmful?
2:55PM - 3:25PM
Richard Bleicher, MD
Q&A
3:25PM - 3:40PM
Adjourn
3:40PM - 3:45PM
Saturday, September 12, 2020
Optional Non-CME: Sponsored by Daiichi Sankyo, Inc. A Specifically Designed ADC that Addresses a Key Unmet Need for Some Patients Previously Treated for HER2+ Unresectable or Metastatic Breast Cancer
8:15AM - 9:00AM
Novel Endocrine Agents
9:00AM - 9:30AM
William J Gradishar, MD
Update on Brain Metastases
9:30AM - 10:00AM
Carey Anders, MD
Stereotactic Body Radiation Therapy for Oligometastases
10:00AM - 10:30AM
Steven Chmura, MD, PhD
Break
10:30AM - 10:45AM
Metastatic Triple Negative Breast Cancer
10:45AM - 11:15AM
Kari Wisinski, MD
Surgery of the Primary Tumor in Stage 4 Breast Cancer
11:15AM - 11:45AM
Seema Khan, MD
Q&A
11:45AM - 12:00PM
Lunch Break & Exhibits
12:00PM - 12:35PM
Optional Non-CME: Sponsored by Genentech Navigating the HER2+ Breast Cancer Treatment Landscape: A Case-Based Clinical Discussion
12:05PM - 12:35PM
Break
12:35PM - 12:40PM
Financial Toxicity of Breast Cancer Treatment
12:40PM - 1:10PM
Reshma Jagsi, MD, PhD
Will Surgery Be a Part of Breast Cancer Therapy in the Future?
1:10PM - 1:40PM
Monica Morrow, MD
Implant Associated Lymphoma
1:40PM - 2:10PM
Jonas Nelson, MD, MPH
Q&A
2:10PM - 2:25PM
Break
2:25PM - 2:40PM
Decision Making for Neoadjuvant Therapy in ER+ Patients
2:40PM - 3:10PM
Otto Metzger, MD
Surgical Issues After Neoadjuvant Endocrine Therapy
3:10PM - 3:40PM
Tari King, MD
Radiotherapy Decision Making After Pathological Complete Response (pCR)
3:40PM - 4:10PM
Julia White, MD
Q&A
4:10PM - 4:25PM

22nd Annual Lynn Sage Breast Cancer Symposium
16.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program will be awarded with a score of 80% or higher.  Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. You will have a maximum of 3 attempts to complete the test successfully.

Please update your Cloud CME profile to include your ABIM ID# in order for points to be properly recorded.
Post-Test

Northwestern University logo

© 2025 Northwestern University

  • Contact Northwestern University
  • Careers
  • Disclaimer
  • Campus Emergency Information
  • University Policies
  • Disclosure
Northwestern University
Feinberg School of Medicine

Giving | Site Feedback

Social Media Center
Facebook
Twitter
LinkedIn
Flickr
YouTube
Instagram
Feinberg School of Medicine
  •  
  • 420 East Superior Street, Suite 9-900
    Chicago, IL 60611-3008
  •  
  • 312-503-8533
  •  
  • 312-503-4531
  •  
  • Email Us

    Live Courses
    RSS Calendar
    Online Courses
    NM My Learning
    Planners
    About
    Help